前10大未平仓空仓比 | 股票名称 | 前次空仓数 | 本次空仓数 | 最新空仓比↓ | | --- | --- | --- | --- | | 中远海控(01919) | 5.26 亿股 | 5.20 亿股 | 18.86% | | 宁德时代(03750) | 2605.32 万股 | 2600.64 万股 | 16.68% | | 中国平安(02318) | 11.52 亿股 | 11.53 亿股 | 15.48% | | 舜宇光学科技(02382) | 1.64 亿股 | 1.64 亿股 | 15.24% | | 东方电气(01072) | 6239.12 万股 | 6166.94 万股 | 15.12% | | 中兴通讯(00763) | 1.10 亿股 | 1.10 亿股 | 14.53% | | 万科企业(02202) | 3.14 亿股 | 3.13 亿股 | 14.16% | | 紫金矿业(02899) | 8.00 亿股 | 8.08 亿股 | 13.50% | | 恒瑞医药(01276) | 3468.60 万股 | 3439.41 万股 | 13.32% | | 药明康德(02359) ...

来源：第一财经 恒生指数收涨0.95%，恒生科技指数涨0.56%。新鸿基地产涨逾7%，药明生物涨逾5%，商汤涨近5%， 中国神华涨逾4%，长实集团、石药集团、药明康德涨逾3%。 ...

| 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( *) 买入营业部 | | | | 卖出营业部 | 是否为专场 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2026-02-27 | 药明康德 | 603259 | 98.01 254.83 | 2.6 | 机构专用 | 發開手落在過程貨 | | Ka | 2月27日，药明康德大宗交易成交2.6万股，成交额254.83万元，占当日总成交额的0.11%，成交价98.01 元，较市场收盘价98.01元持平。 ...

随着近期多只生物医药股靓丽业绩放榜，今日港股创新药概念也集体活跃。其中，入选了2026年格隆 汇"下注中国"十大核心资产名单的药明合联涨超8%，领涨板块，药明生物涨超5%，康方生物、云顶新 耀、诺诚健华涨超4%，石药集团、再鼎医药、药明康德涨超3%。 | 代码 | 名称 | | 涨跌幅 V | 最新价 | 总市值 | 年初至今涨跌 | | --- | --- | --- | --- | --- | --- | --- | | 02268 | 药明合联 | 0 | 8.40% | 63.250 | 795.68亿 | 4.12% | | 02269 | 药明生物 | | 5.38% | 40.340 | 1669.08 Z | 28.31% | | 09926 | 康方生物 | | 4.81% | 106.800 | 983.78亿 | -5.49% | | 01952 | 云顶新耀 | | 4.27% | 37.600 | 132.95亿 | 1.68% | | 69660 | 诺成健华 | | 4.04% | 12.090 | 213.04亿 | -1.71% | | 01093 | 石约集团 | | 3. ...

Group 1 - CXO concept stocks have shown significant gains, with WuXi AppTec (02268) rising by 7.97% to HKD 63, WuXi Biologics (02269) increasing by 4.7% to HKD 40.08, WuXi PharmaTech (603259) (02359) up by 2.28% to HKD 19.7, and Kanglong Chemical (300759) (03759) also up by 2.28% to HKD 19.7 [1] - According to a report from Citi, investor focus is shifting from AI-enabled industries to AI replacing intermediaries, with a clearer positive impact expected on Contract Research, Development, and Manufacturing Organizations (CRDMO) compared to the mixed effects on Contract Research Organizations (CRO) due to internal AI adoption by pharmaceutical companies [1] - The report indicates that the recent decline in the sector is not driven by fundamentals but rather by position adjustments and capital flows, suggesting that the current pullback is a technical/short-term fluctuation rather than a deterioration in demand or execution [1] Group 2 - The report highlights that leading companies in the industry may experience overselling during this market window lacking catalysts, creating attractive entry points for investors with a 3 to 12-month investment horizon [1]

每经AI快讯，2月27日，港股CXO概念股涨幅居前，药明合联(02268.HK)涨7.97%，报63港元；药明生 物(02269.HK)涨4.7%，报40.08港元；药明康德(02359.HK)涨2.28%，报19.7港元；康龙化成(03759.HK) 涨2.28%，报19.7港元。 ...

Group 1 - The core viewpoint of the article highlights the recent performance of CXO concept stocks, with notable gains in companies such as WuXi AppTec (02268) up 7.97% to HKD 63, WuXi Biologics (02269) up 4.7% to HKD 40.08, WuXi PharmaTech (02359) up 2.28% to HKD 19.7, and Kanglong Chemical (03759) also up 2.28% to HKD 19.7 [1] - According to a report from Citi, the focus of investors is shifting from AI-enabled industries to AI replacing intermediaries, with a clearer positive impact expected on Contract Research, Development, and Manufacturing Organizations (CRDMO) compared to the mixed effects on Contract Research Organizations (CRO) due to the accelerated adoption of AI by pharmaceutical companies [1] - The report indicates that the recent decline in the sector is not driven by fundamentals but rather by position adjustments and capital flows, suggesting that the current pullback is a technical/short-term fluctuation rather than a deterioration in demand or execution [1] Group 2 - The report emphasizes that leading companies in the industry may experience overselling during this market window lacking catalysts, creating more attractive entry points for investors with a 3 to 12-month investment horizon [1]

Group 1: Market Overview - The Hang Seng Index opened high but closed down 384 points, or 1.44%, at 26,381 points, with significant selling pressure observed throughout the day [3][4] - The market saw a total turnover of 25.93 billion HKD, with net outflow from northbound trading amounting to 736.6 million HKD [3] Group 2: Company Performance - NIO's subsidiary GeniTech secured over 2.257 billion RMB in investment from Chinese investors, maintaining a 62.7% controlling stake post-transaction [12] - New World Department Store China reported a 3.93 times increase in interim profit to 15.327 million HKD, despite a 12.44% decrease in revenue to 536 million HKD [13] - Chow Tai Fook Jewelry Group announced a 15.26% increase in interim profit to 1.334 billion HKD, with revenue rising 5.9% to 12.827 billion HKD [14] - Baidu reported a 65.68% decrease in net profit to 1.782 billion RMB for the fourth quarter, with total revenue declining 4.06% to 32.74 billion RMB [15] Group 3: Industry Developments - Hong Kong Exchanges and Clearing is exploring the development of a multi-asset tokenization platform, contingent on technological capabilities and market demand [7] - The People's Bank of China issued a notice to enhance the management of RMB cross-border interbank financing, aiming to improve transparency and stability in offshore RMB liquidity [10] - The Hong Kong government plans to inject 10 billion HKD into the Hong Kong-Shenzhen Innovation and Technology Park and the New Territories Science Park to bolster public-private partnerships [9]

来源：格隆汇APP 格隆汇2月27日｜港股主要指数午后拉升，其中，恒生指数涨超1%，恒生科技指数涨近1%，国企指数 涨0.74%。恒生指数成分股中，新鸿基地产涨超6%领涨，药明生物涨超4%，石药集团、药明康德涨超 3%，网易、携程、腾讯、泡泡玛特、蒙牛乳业、中通快递涨超2%。 | 代码 | 名称 | | 涨跌幅 √ | 年初至今涨跌 | 总市值 | | --- | --- | --- | --- | --- | --- | | 00016 | 新鸿基地产 | (0) | 6.02% | 52.59% | 4187.29 Z | | 02269 | 药明生物 | | 4.81% | 27.61% | 1659.98亿 | | 01093 | 石药集团 | | 3.67% | 17.32% | 1139.57亿 | | 02359 | 药明康德 | | 3.04% | 20.36% | 3544.7 Z | | 099999 | 网易-S | | 2.74% | -16.22% | 5692.45 Z | | 09961 | 携程集团-S | | 2.60% | -25.85% | 2685亿 | | 00700 ...

(本文来自第一财经) 百济神州跌超8%，药明生物跌超7%，泰格医药、康龙化成跌超5%，君实生物、药明康德、诺诚健华等 跟跌。 ...